CA
Can-Fite BioPharma Ltd.
CANF · AMEX
$2.28 +1.79% (+$0.04)
1M -33.13%
Market Cap $2.96M
P/E Ratio -
Div. Yield -
ROE 201.06%
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair P/S 7.31x
P/B 0.53x
P/E N/A
Growth
15 /100
Declining Rev. growth 20.42%
Book val. growth 7.73%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 2,426.67%
Op. margin 2,456.79%
Quality
1 /100
Poor ROIC 145.49%
ROE 201.06%
ROA 103.30%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 3.46x
Int. coverage N/A
Stability
20 /100
Unstable Beta 0.02x
Rev. volatility 17.71%
EPS volatility 611.96%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na CANF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Motti Farbstein
Employees
5
Headquarters
Ramat Gan
Nadcházející události
01 DUB
Earnings
Upcoming earnings report